Product Information

CELECOXIB 50 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0680 per EA under NDC 33342015509. Its NADAC has been published 498 times since May 10, 2017.

FDA first approved this application on Mar 16, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CELECOXIB 50 MG CAPSULE

celecoxib
$0.0680per EA

Strength

50 mg/1

NDC

33342015509

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CELECOXIB

Approval Type

Generic (ANDA)

FDA Application

ANDA204590

FDA Approved

3/16/2016

TE Code

AB

On Market Since

3/16/2016

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CELECOXIB 50 MG CAPSULE has been published 498 times since May 10, 2017, and over the history we have for it it has declined 80.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0680 per EA
All-time high$0.4143 (Aug 16, 2017)
All-time low$0.0492 (Nov 20, 2024)
52-week high$0.1073
52-week low$0.0680
Median price$0.1456
Average price$0.1790
Largest weekly change+128.0% (Jan 19, 2022)
Weeks tracked498
Tracking sinceMay 10, 2017

Price History

1W

-16.3%

1M

-25.6%

3M

-23.0%

6M

-31.8%

1Y

-20.4%

3Y

-28.5%

5Y

-63.7%

All

-80.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CELECOXIB 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 50 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.0680 per EA (NDC 33342015509), effective Nov 18, 2026.

How has the price of CELECOXIB 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CELECOXIB 50 MG CAPSULE has declined 80.8%. It has been tracked across 498 weekly CMS publications since May 10, 2017.

What are the highest and lowest recorded NADAC prices for CELECOXIB 50 MG CAPSULE?

Since May 10, 2017, the NADAC for CELECOXIB 50 MG CAPSULE has ranged from a low of $0.0492 (Nov 20, 2024) to a high of $0.4143 (Aug 16, 2017), with a median of $0.1456 per EA.

Are there cheaper alternatives to CELECOXIB 50 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CELECOXIB 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CELECOXIB 50 MG CAPSULE?

CELECOXIB 50 MG CAPSULE (NDC 33342015509) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.